Molecular Detection of <i>Herpesviridae</i> (HSV 1/2, VZV, EBV, CMV, HHV-6) among Patients with Encephalitis in Côte d’Ivoire

Background: Encephalitis is a serious neurological syndrome that can be caused by various infectious agents, particularly in immunocompromised individuals. Among these agents, viruses from the Herpesviridae family play a major role, although their diagnosis is often underestimated and their involvement remains poorly understood, particularly in developing countries such as those in West Africa. Aim: This cross-sectional, descriptive, multicenter study was conducted in hospitals in two regions of Côte d’Ivoire, namely Abidjan and Bouaké, between March 2024 and April 2025 to assess the prevalence of herpesviruses. Methods: CSF samples were collected from patients aged ≥ 15 years who presented with clinical signs of encephalitis and were subjected to molecular analysis. Viral DNA extraction and PCR tests were used to detect Herpes simplex virus 1 and 2 (HSV 1/2), Varicella-Zoster virus (VZV), Epstein-Barr virus (EBV), Cytomegalovirus (CMV), and Human herpesvirus 6 (HHV6). Clinical data and molecular analysis results were recorded using Excel software, and statistical analysis was performed using RStudio 4.2.1 software. Results are presented as mean and standard deviation for quantitative variables and as percentages for qualitative variables. Results: A total of 388 patients were included in this study (222 women and 166 men; age range 15 - 79 years; mean age 45.36 ± 13.55 years), and 60 (15.46%) were positive for one or more herpesvirus. Epstein-Barr virus was most frequently detected in 33 (55.00%) of positive cases, followed by Cytomegalovirus with 20 (33.33%) and Varicella-Zoster virus and Human herpes virus 6 with respective rates of 20.00% (12) for VZV and 11.67% (07) for HHV6. A single Herpes simplex virus (1.67%) was detected. Among the patients with a positive PCR, 10 (16.67%) were co-infected with herpesviruses. All co-infected patients were HIV seropositive. The chi-square test showed a significant association between HIV infection status and the molecular detection of herpesvirus in patients with encephalitis (OR 3.9; 95% CI: [1.4 - 9.3]; P Conclusion: Herpesviruses are a significant cause of encephalitis, particularly in immunocompromised and immunocompetent patients. In our study, EBV and CMV were the most common. Therefore, the rapid identification of these viruses in the CSF and the initiation of appropriate antiviral treatment are essential to reduce mortality and improve the management of patients with encephalitis. Furthermore, the development of new antiviral molecules, optimization of therapeutic strategies, and improvement of diagnostic techniques would provide prospects for better control of these infections.

Authors

Publication Details

Journal
Advances in Bioscience and Biotechnology
Published
2025-01-01
DOI
https://doi.org/10.4236/abb.2025.168019
Primary Topic
Herpesvirus Infections and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Molecular Detection of Herpesviridae (HSV 1/2, VZV, EBV, CMV, HHV-6) among Patients with Encephalitis in Côte d’Ivoire

A. Coulibaly, Pacôme Monemo, Kalpy Julien Coulibaly, Kouadio Stéphane Koffi et al.
Advances in Bioscience and Biotechnology
Herpesvirus Infections and Treatments
article

Molecular Detection of Herpesviridae (HSV 1/2, VZV, EBV, CMV, HHV-6) among Patients with Encephalitis in Côte d’Ivoire

A. Coulibaly, Pacôme Monemo, Kalpy Julien Coulibaly, Kouadio Stéphane Koffi, Edgard Adjogoua, Sodji Emilie Karen N’goran, Eric Essoh Akpa, A. Bamba, Z. Diallo, Fiacre Delord Offoumou, Mbodje Ophélia Gnamon, Kobina Amandze Adams Kofi, Flora Ahonzo
article en

Abstract

Background: Encephalitis is a serious neurological syndrome that can be caused by various infectious agents, particularly in immunocompromised individuals. Among these agents, viruses from the Herpesviridae family play a major role, although their diagnosis is often underestimated and their involvement remains poorly understood, particularly in developing countries such as those in West Africa. Aim: This cross-sectional, descriptive, multicenter study was conducted in hospitals in two regions of Côte d’Ivoire, namely Abidjan and Bouaké, between March 2024 and April 2025 to assess the prevalence of herpesviruses. Methods: CSF samples were collected from patients aged ≥ 15 years who presented with clinical signs of encephalitis and were subjected to molecular analysis. Viral DNA extraction and PCR tests were used to detect Herpes simplex virus 1 and 2 (HSV 1/2), Varicella-Zoster virus (VZV), Epstein-Barr virus (EBV), Cytomegalovirus (CMV), and Human herpesvirus 6 (HHV6). Clinical data and molecular analysis results were recorded using Excel software, and statistical analysis was performed using RStudio 4.2.1 software. Results are presented as mean and standard deviation for quantitative variables and as percentages for qualitative variables. Results: A total of 388 patients were included in this study (222 women and 166 men; age range 15 - 79 years; mean age 45.36 ± 13.55 years), and 60 (15.46%) were positive for one or more herpesvirus. Epstein-Barr virus was most frequently detected in 33 (55.00%) of positive cases, followed by Cytomegalovirus with 20 (33.33%) and Varicella-Zoster virus and Human herpes virus 6 with respective rates of 20.00% (12) for VZV and 11.67% (07) for HHV6. A single Herpes simplex virus (1.67%) was detected. Among the patients with a positive PCR, 10 (16.67%) were co-infected with herpesviruses. All co-infected patients were HIV seropositive. The chi-square test showed a significant association between HIV infection status and the molecular detection of herpesvirus in patients with encephalitis (OR 3.9; 95% CI: [1.4 - 9.3]; P Conclusion: Herpesviruses are a significant cause of encephalitis, particularly in immunocompromised and immunocompetent patients. In our study, EBV and CMV were the most common. Therefore, the rapid identification of these viruses in the CSF and the initiation of appropriate antiviral treatment are essential to reduce mortality and improve the management of patients with encephalitis. Furthermore, the development of new antiviral molecules, optimization of therapeutic strategies, and improvement of diagnostic techniques would provide prospects for better control of these infections.

Advances in Bioscience and BiotechnologyVol. 16(08)
Openalex Percentile: Top 71%
Herpesvirus Infections and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.